We’re always excited to find bio/pharma companies nearing their therapeutic product launch! These 4 companies have FDA final approval decision (PDUFA) dates before the end of January: Atara Biotherapeutics (NASDAQ: ATRA ) Drug/Therapy: Tab-cel (tabelecleucel) Allogeneic T-cell immunotherapy Indication: Post-Transplant Lymphoproliferative Disease (PTLD) PDUFA date: January 15, 2025 BLA with priority review Biogen (NASDAQ: BIIB ) Drug/Therapy: Leqembi (Lecanemab) IV Maintenance

We’re always excited to find bio/pharma companies nearing their therapeutic product launch!

$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $83.17 | +1.59% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $83.17 | +1.59% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...